Mengxin Xu
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
A potent Gc neutralizing antibody reveals architecture-dependent bispecific protection against SFTSV.
Journal: Emerging microbes & infections
Published: March 27, 2026
Human monoclonal antibodies isolated after seasonal vaccination broadly neutralize antigenically drifted influenza B viruses.
Journal: Cell host & microbe
Published: August 27, 2025
Corrigendum to "IgA class switching enhances neutralizing potency against SARS-CoV-2 by increased antibody hinge flexibility" [Antiv. Res. (2025) 106082].
Journal: Antiviral research
Published: March 21, 2025
Broad neuraminidase antibodies confer protection against seasonal and avian influenza viruses.
Journal: Nature communications
Published: February 24, 2025
IgA class switching enhances neutralizing potency against SARS-CoV-2 by increased antibody hinge flexibility.
Journal: Antiviral research
Published: September 29, 2024
Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1.
Journal: Signal transduction and targeted therapy
Published: December 11, 2023
RBD class 1 and 2 antibody epitopes elicit around 70% neutralizing capacity against SARS-CoV-2 virus following boosting with inactivated virus vaccine.
Journal: Vaccine
Published: June 22, 2023
Spike substitution T813S increases Sarbecovirus fusogenicity by enhancing the usage of TMPRSS2.
Journal: PLoS pathogens
Published: January 14, 2023
The protective nasal boosting of a triple-RBD subunit vaccine against SARS-CoV-2 following inactivated virus vaccination.
Journal: Signal transduction and targeted therapy
Published: October 13, 2022
Comparative global B cell receptor repertoire difference induced by SARS-CoV-2 infection or vaccination via single-cell V(D)J sequencing.
Journal: Emerging microbes & infections
Published: July 28, 2022
Last Updated: 09/26/2026